20 December 2016

Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint may contribute to the pathophysiology and clinical symptoms.

Inflammatory diseases

Arjen Blom (photo up), theme Inflammatory diseases will focus on the involvement of the alarmins S100A8 and -A9 in pain behavior during experimental osteoarthritis (OA). The sequence of events that leads to pain via alarmins will be studied both in experimental OA and in a human trial. 

Peter van Lenttheme Inflammatory diseases will develop new inhibitors for S100A8/A9 heterodimerization for dampening synovial inflammation and joint destruction in osteoarthritis. 

The group of Peter van Lent has significantly contributed in understanding the role of alarmins S100A8/A9 in inflammation and joint destruction in osteoarthritis.

Related news items


Ignacio Malagon, first professor of Pediatric Anaesthesiology in the Netherlands

21 January 2019

Ignacio Malagon has been appointed professor of Pediatric Anaesthesiology at Radboud University / Radboud university medical center with effect from 1 January 2019. He is the first professor in this field in the Netherlands.

read more

Thomas Maal appointed full professor of 3D Technology in Healthcare

7 January 2019

3D technology leads to better care and lower costs.

read more

Quickly detecting actual heart attacks prevents unnecessary hospital visits Research by Radboud university medical center improves efficacy and reduces cost of cardiac care

4 January 2019

Many patients who suffer from chest pain are not actually having a heart attack, making an emergency hospital visit unnecessary. Is there a way to quickly and accurately determine at home whether emergency hospital treatment is necessary?

read more

Radboud university medical center treats metastatic liver cancer with holmium microspheres MRI imaging during surgery can improve the outcome

4 January 2019

For the first time Radboud university medical center has treated a patient with liver metastases by using holmium radio-embolization. With this technique, radioactive holmium microspheres are injected via a catheter into the liver artery.

read more

Research into drugs for treating rare diseases can be more efficient and patient-oriented

18 December 2018

To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).

read more